(VIANEWS) – Shares of Viking Therapeutics (NASDAQ: VKTX) jumped by a staggering 21.53% in 7 days from $2.88 to $3.50 at 15:59 EST on Monday, after four consecutive sessions in a row of gains. NASDAQ is sliding 0.26% to $12,624.09, following the last session’s downward trend.
Viking Therapeutics’s last close was $3.43, 66.01% under its 52-week high of $10.09.
Today’s last reported volume for Viking Therapeutics is 327936 which is 72.21% below its average volume of 1180283.
The company’s growth estimates for the current quarter and the next is a negative 61.5% and a negative 46.7%, respectively.
Viking Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was 4.67%, 0.04%, and 4.34%, respectively.
Viking Therapeutics’s highest amplitude of average volatility was 9.23% (last week), 3.85% (last month), and 4.34% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Viking Therapeutics’s stock is considered to be oversold (<=20).
Viking Therapeutics’s Stock Yearly Top and Bottom Value
Viking Therapeutics’s stock is valued at $3.50 at 15:59 EST, way below its 52-week low of $4.81.
Viking Therapeutics’s Moving Average
Viking Therapeutics’s worth is way under its 50-day moving average of $5.82 and way below its 200-day moving average of $6.03.
More news about Viking Therapeutics (VKTX).